Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

BACKGROUND AND AIMS: Chronic hepatitis B (CHB) patients rarely achieve hepatitis B surface antigen (HBsAg) loss with nucleoside/nucleotide analog therapy. METHODS: In this retrospective study, it was evaluated that the rate of HBsAg loss in the HBe antigen negative (HBeAg(−)) patients (n=101) treate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Infect Drug Resist
Egile Nagusiak: Yan, Lei, Zhu, Chuanwu, Li, Jing, Chen, Liwen, Ding, Yezhou, Cao, Zhujun, Liu, Kehui, Lin, Lanyi, Tang, Weiliang, Xie, Qing, Xu, Yumin, Bao, Shisan, Wang, Hui
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6211310/
https://ncbi.nlm.nih.gov/pubmed/30464542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S175707
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak